July 23, 2024
NovaSight, an Israeli Health-Tech company focusing on eye-tracking-based vision care solutions, is developing TrackSight, a software-as-a-service (SaaS) solution for managing and reducing myopia progression. TrackSight is a pipeline solution utilizing the same technology as the company’s flagship product, CureSight, an FDA-cleared and CE-marked eye-tracking-based digital system designed for remote binocular treatment of amblyopia in pediatric patients (ages 4 to 9). TrackSight for myopia management is designed to run on laptops, tablets, and smartphones and is intended to be used by children and young adults for both educational and leisure purposes.
Real-Time Digital Peripheral Blur
The reduction of myopia progression is achieved by real-time digital peripheral blur on the user’s screen, which is based on the momentary gaze position. The efficacy of contrast reduction along the peripheral retinal image for myopia control was first demonstrated by the SightGlass Vision spectacle lenses that use Diffusion Optics Technology (DOT).1 The SightGlass Vision spectacles lenses induce light-scattering elements on the lens, which reduces the image contrast along the peripheral area while maintaining a clear area in front of the pupil to allow clear central vision. A randomized controlled clinical study with SightGlass Vision’s myopia control spectacle glasses showed a slowdown of axial length progression of 50% (at 12 months).
However, all spectacle lens-based solutions deliver a static correction that degrades acuity when moving the eyes out of the center of the lens. This downflow is solved by the eye-tracking-based TrackSight dynamic solution, which induces tailored peripheral image contrast degradation. This digital method allows natural eye movement when viewing screens at a near distance without affecting the on-axis acuity, which does not disrupt the user’s experience as opposed to when the user moves his eyes through the spectacle lenses approach. Moreover, it is hypothesized that TrackSight may offer an increased therapeutic effect due to the ability to generate a smaller diameter of the clear central area, increasing the therapeutic zone compared to the larger diameter of the clear area of static myopia control lenses, offering some degree of eye movement without affecting the on-axis acuity due to the eye-tracking based dynamic compensation for the eye movements.
Built-In Myopia Prevention Module
Since myopic kids tend to remove their glasses when looking at near and intermediate distances, such as watching screens, further myopia progression occurs since laptops and tablets currently do not offer any myopia control solutions. TrackSight-equipped devices will have a built-in myopia prevention module running in the background, similar to the accessibility modes on laptops and tablets. Though TrackSight is intended for personal use, the solution could also be used by schools where children use computers for educational purposes.

TrackSight for myopia management is designed to run on laptops, tablets, and smartphones and is intended to be used by children and young adults for both educational and leisure purposes.
“Introducing TrackSight into computer screens and tablets offers substantial benefits in managing and preventing myopia progression for both children and teenagers. Leveraging our eye-tracking technology across diverse vision care solutions represents a remarkable step towards digitalizing the field of vision care,” says Ran Yam, CEO and Co-Founder of NovaSight.
Go-To-Market Strategy
NovaSight has begun discussions with leading consumer electronics manufacturers about integrating TrackSight into laptops and tablets, utilizing the device’s built-in cameras. Initially, end users will be able to purchase the license directly from the company and install the software remotely (if working with integrated cameras) or through an already installed application on a dedicated computer or embedded directly on screens. As a result of working with global consumer electronics giants, TrackSight is poised to become the world’s standard computer vision protection solution, gaining access to huge markets and solidifying its position in the industry.
Backed by the soon-to-be-completed B-Round funds, NovaSight is planning a feasibility study to evaluate the immediate response of the retina’s choroid layer thickness, followed by a 12-month pilot study. Upon completion of the pilot study, a larger multicenter pivotal trial in the U.S., China, Israel, and Singapore will commence. Following the pilot study’s results, TrackSight’s concept may be relevant for early commercialization as a wellness application.
References
1 Rappon, J., Chung, C., Young, G., Hunt, C., Neitz, J., Neitz, M., & Chalberg, T. (2023). Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). British Journal of Ophthalmology, 107(11), 1709-1715.
